Ontario’s plunging price-caps on generics: deeper dives may drown some drugs

Abstract

In April 2010, the Ontario government announced another reduction in the maximum price of generic drugs permitted under the Ontario Drug Benefit (ODB) program, demanding that generic drugs now be sold for no more than 25% of the branded product's price. Other provinces are following Ontario in setting unprecedentedly low price-caps to reduce the cost of generic drugs. Generic product substitution legislation is vital to reducing costs to provincial drug plans, yet lower and lower price-caps may undo some of the benefits of substitution legislation if generics find it difficult to survive.

Extracted Key Phrases

Cite this paper

@inproceedings{Anis2011OntariosPP, title={Ontario’s plunging price-caps on generics: deeper dives may drown some drugs}, author={Aslam Hayat Anis and Stephanie S Harvard and Carlo Marra}, booktitle={Open medicine : a peer-reviewed, independent, open-access journal}, year={2011} }